Key Findings:  The authors conclude that A. conyzoides essential oil and caryophyllene may represent novel drugs to treat neuropathic pain.
Type of Study:  Animal Study
Study Result:  Positive
Research Location(s):  Indonesia
Year of Pub:  2022
Cannabinoids Studied: 
Phytocannabinoid Source:  Not Applicable
Terpenes Studied:  ß-Caryophyllene
Ligands Studied:  GABA
Citation:  Sukmawan YP, et al. Anti-neuropathic Pain Mechanistic Study on A. conyzoides Essential Oil, Precocene II, Caryophyllene, or Longifolene as Single Agents and in Combination with Pregabalin. CNS Neurol Disord Drug Targets. 2023; 22:924-931. doi: 10.2174/1871527321666220418121329
Authors:  Sukmawan YP, Anggadiredja K, Adnyana IK